What should you know about the latest treatment for metastatic prostate cancer?

The latest treatment for metastatic prostate cancer is chosen as a combination plan based on where the cancer has spread, prior treatment, symptoms, and overall health. Care may include hormone-directed medicines, additional systemic treatment, radiation to selected areas, and support for bone health.

Medicines that reduce or block hormone signalling are often central because prostate cancer cells can respond to these signals. Other medicines may be added according to tumour behaviour and previous treatment. Radiotherapy can relieve symptoms or treat selected sites, while targeted radioisotope therapy may suit some cancers with particular features. Bone-strengthening therapy and pain control address complications in the skeleton. A prostatectomy is not usually the main treatment once disease is metastatic, but the team will individualise decisions.

Ask where the cancer is located, what the treatment goal is, and whether tests can identify options suited to its biology. Report pain, urinary changes, weakness, numbness, tiredness, and medicine effects. Keep an updated medicine list and tell the team about dental problems before bone-directed treatment is started.

Get urgent help for new leg weakness, numbness around the groin, loss of bladder or bowel control, or severe back pain, as these can signal pressure on the spinal nerves. Urgent review is also needed for inability to pass urine, severe breathlessness, confusion, or a fever during treatment.

Ask which combination is recommended and why, how response will be checked, and what happens if the cancer changes. Discuss pain relief, urinary support, bone protection, exercise, nutrition, sexual health, and which symptoms require same-day contact.